Search - tctmd.com

Displaying 281 - 300 of 471

Sort: Relevancy | Date

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

Todd Neale

October 14, 2019

News Daily News

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

L.A. McKeown

October 09, 2019

News Daily News

Interventional Options and Future Directions for Acute PE: New AHA Statement

Todd Neale

October 07, 2019

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

Presentation TCT 2019

Distal Embolic Protections Are Expensive and Have Inherent Risks: When Are They Absolutely Necessary?

Presenter: Peter Schneider

September 25, 2019

News Daily News

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

Caitlin E. Cox

September 20, 2019

News Daily News

PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis

Caitlin E. Cox

August 15, 2019

News Daily News

AHA Outlines Diagnosis, Treatment Options for Underrecognized Critical Limb Ischemia

Caitlin E. Cox

August 12, 2019

News Daily News

In Carotid RCTs, Outcomes Improved Over Time for CEA but not CAS: Meta-analysis

Caitlin E. Cox

August 09, 2019

News Industry News

Boston Scientific Responds to the FDA’s Guidance on Use of Peripheral Paclitaxel Devices for Treatment of PAD

August 07, 2019

News Daily News

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

Caitlin E. Cox

July 30, 2019

News Opinion Off Script

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

Sahil Parikh, MD

July 29, 2019

News Industry News

Thrombolex, Inc. Announces First Patient Enrolled in Early Feasibility & Safety Study Using the Bashir™ Endovascular Catheter for Pulmonary Embolism

July 29, 2019

News Industry News

New study finds both components of blood pressure predict heart attack, stroke risk

July 17, 2019

News Daily News

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

Caitlin E. Cox

July 11, 2019

News Daily News

Microvascular Disease Quadruples Risk of Leg Amputation

L.A. McKeown

July 08, 2019

News Industry News

Medtronic HeartWare(TM) HVAD(TM) Implanted via Less Invasive Thoracotomy Shows 95 Percent Freedom from Disabling Stroke at Two Years

July 08, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2019

Shelley Wood

June 28, 2019

News Daily News

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

L.A. McKeown

June 20, 2019

News Daily News

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

L.A. McKeown

June 19, 2019

Advertisement

FDA Gives Rivaroxaban Another VTE-Related Indication

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

Interventional Options and Future Directions for Acute PE: New AHA Statement

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

Distal Embolic Protections Are Expensive and Have Inherent Risks: When Are They Absolutely Necessary?

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis

AHA Outlines Diagnosis, Treatment Options for Underrecognized Critical Limb Ischemia

In Carotid RCTs, Outcomes Improved Over Time for CEA but not CAS: Meta-analysis

Boston Scientific Responds to the FDA’s Guidance on Use of Peripheral Paclitaxel Devices for Treatment of PAD

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty

Thrombolex, Inc. Announces First Patient Enrolled in Early Feasibility & Safety Study Using the Bashir™ Endovascular Catheter for Pulmonary Embolism

New study finds both components of blood pressure predict heart attack, stroke risk

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

Microvascular Disease Quadruples Risk of Leg Amputation

Medtronic HeartWare(TM) HVAD(TM) Implanted via Less Invasive Thoracotomy Shows 95 Percent Freedom from Disabling Stroke at Two Years

TCTMD’s Top 10 Most Popular Stories for June 2019

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

FDA Advisors Face ‘Forest of Dueling Numbers’ at Paclitaxel PAD Device Review: Day One

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content